Xavier Pi-Sunyer, the Columbia University obesity specialist who ran Sanofi's trials, sees the drug being used mostly for morbidly obese patients, not to help anyone fit into a swimsuit.

FORBES: French drug giant Sanofi prepares for fat city.

On my last visit to one, I watched a morbidly obese patient die, while slumped over in his wheelchair, among the 30 patients lined up that morning to see the doctor.

FORBES: Those Pesky Implementation Details

Though intended only for the morbidly obese (those with 45 kilos or more of excess weight), the surgery is attracting the attention of thinner patients who want a quick fix.

FORBES: Magazine Article